Clinical Trial Update: 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis. [Phase 3]

View source ↗

Summary

Completed Phase 3 trial evaluating the suitability of the RebiSmart auto-injector for self-injection in relapsing multiple sclerosis patients treated with Rebif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Rebif (interferon beta-1a)

Snippet

Sponsor: EMD Serono | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2010-08-11